Kei Nakajima
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Diet, Metabolism, and Disease 10
- Biochemistry top 5%
- Physiology top 5%
- Diet and metabolism studies 9
- Nutrition and Health in Aging 7
- Nephrology top 5%
-
- Liver Disease Diagnosis and Treatment 18
-
- Lipoproteins and Cardiovascular Health 10
- Pancreatitis Pathology and Treatment 7
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Co-authors
- Kaname SuwaToshitaka MuneyukiMitsuo OhniYasuhiro NakamuraYoshiki HataToshiaki TakanoMasakazu YamamotoHiromi Munakata
- Journals
- SHILAP Revista de lepidopterología (3 papers)Blood (3 papers)PLoS ONE (4 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Kei Nakajima
123 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 129
- Endocrinology, Diabetes and Metabolism 452
- Biochemistry 150
- Physiology 512
- Nephrology 132
- Pathology and Forensic Medicine 253
Countries citing papers authored by Kei Nakajima
This map shows the geographic impact of Kei Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Nakajima more than expected).
Fields of papers citing papers by Kei Nakajima
This network shows the impact of papers produced by Kei Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Nakajima. The network helps show where Kei Nakajima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kei Nakajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2015 | 18 | |
| 14 | 2015 | 15 | |
| 15 | 2013 | 16 | |
| 16 | 2011 | 29 | |
| 17 | 2009 | 47 | |
| 18 | 2009 | 22 | |
| 19 | 2004 | 23 | |
| 20 | 2000 | 8 |
About Kei Nakajima
Kei Nakajima is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Hematology, having authored 128 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Liver Disease Diagnosis and Treatment (18 papers), Lipoproteins and Cardiovascular Health (10 papers), Diet, Metabolism, and Disease (10 papers), Diet and metabolism studies (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Nutrition and Health in Aging (7 papers) and Pancreatitis Pathology and Treatment (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (452 citations), Biochemistry (150 citations) and Physiology (512 citations). Kei Nakajima has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Kaname Suwa, Toshitaka Muneyuki, Mitsuo Ohni, Yasuhiro Nakamura, Yoshiki Hata, Toshiaki Takano, Masakazu Yamamoto, Hiromi Munakata, Toshimitsu Ito and Eiichiro Kanda. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.